Skip to content

Vivani Medical VANI Deferred Tax Assets

Deferred Tax Assets at other companies

Eli Lilly logo
Eli LillyLLY
$11.35B+32.4%
Altimmune logo
AltimmuneALT
-$681K

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's deferred tax assets?
Vivani Medical (VANI) reported deferred tax assets of $2.41M in Q4 2025.
How has Vivani Medical's deferred tax assets changed year-over-year?
Vivani Medical's deferred tax assets increased by 20.8% year-over-year, from $1.99M to $2.41M.
What is the long-term trend for Vivani Medical's deferred tax assets?
Over 5 years (2020 to 2025), Vivani Medical's deferred tax assets has grown at a 44.7% compound annual growth rate (CAGR), from $380K to $2.41M.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.